LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Cyclin D1 is one of the most important oncoproteins that drives cancer cell proliferation and associates with tamoxifen resistance in breast cancer. Here, we identify a lncRNA, DILA1, which interacts with Cyclin D1 and is overexpressed in tamoxifen-resistant breast cancer cells. Mechanistically, DIL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nat Commun
Autori principali: Shi, Qianfeng, Li, Yudong, Li, Shunying, Jin, Liang, Lai, Hongna, Wu, Yanqing, Cai, Zijie, Zhu, Mengdi, Li, Qian, Li, Ying, Wang, Jingru, Liu, Yujie, Wu, Zongqi, Song, Erwei, Liu, Qiang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608661/
https://ncbi.nlm.nih.gov/pubmed/33139730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19349-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi